We are thrilled to have had the opportunity to attend the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA. Your interest in our research progress and the insightful discussions we had about your projects and objectives truly made our experience at AACR memorable. These exchanges are invaluable in advancing our collective efforts in cancer research.
Below, you will find all of the poster presentations from the conference available for download!
| Targets | Platform | Poster Title (click to download) |
| CCR8 | RenMabTM mice | Identification of fully human CCR8 antibodies that demonstrate excellent ADCC function, potent blocking activity, and robust anti-tumor immune responses |
| Targets | Platform | Poster Title (click to download) |
| KRAS | TCR-Mimic Antibody Platform | Targeting mutant KRAS proteins with novel TCR-mimic fully human antibodies |
Syncromune’s Oral Presentation:
Our therapeutic antibody collaborator Syncromune delivered an oral presentation unveiling clinical data of its SYNC-T technology for the first time! The preliminary clinical results of SYNC-T SV-102, which features our clinical-stage CTLA-4 monoclonal antibody YH001 and CD40 agonistic monoclonal antibody YH003, have showcased an exceptional 85% overall response rate among patients battling metastatic castrate-resistant prostate cancer.
AACR News Release | GlobeNewswire | AACR2024 Abstract
CtM Bio’s Poster Presentation
Title: A novel tri-specific T cell engager targeting the intracellular oncoprotein WT1
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other healthcare professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. (Source: AACR)
